Differentiation between Chronic Focal Pancreatitis and Pancreatic Cancer by Proton MR Spectroscopy: Correlation with Pathologic Results

초록

목적:To know the differences of proton MR spectroscopic features between chronic focal pancreatitis and pancreatic cancer, and to evaluate the possibility to discriminate chronic focal pancreatitis from pancreatic cancer by analysis of the proton MR spectra. 방법:We evaluated the proton MR spectra from 33 human pancreases. Our series included 15 cases of chronic focal pancreatitis and 18 cases of pancreatic cancer. Twenty-two men and 11 women were included in our series. All cases of chronic focal pancreatitis and pancreatic cancer were confirmed by histopathology after surgical resection. Proton MR spectroscopy (1H-MRS) was performed at 1.5T GE Signa Horizon (GE Medical System, Milwaukee, USA) system using localized proton STEAM sequence and body coil in all cases with subjects were located in supine position. No respiratory interruption was required during the spectroscopic signal acquisition. Parameters using in MRS were: TR = over 3000ms, TE = 30ms, number of scans = 128, voxel size = 8 (2x2x2)cm³, and one NEX. We evaluated the spectra with an attention to the differences of patterns of the curves between chronic focal pancreatitis and pancreatic cancer. The ratio of peak area of all peaks at 1.6-4.1ppm to lipid (0.9-1.6ppm) [P(1.6-4.1ppm)/P(0.9-1.6ppm)] was calculated in chronic focal pancreatitis and pancreatic cancer group, and compared the results between these groups. We also evaluated the sensitivity and specificity for discriminating chronic focal pancreatitis from pancreatic cancer by analysis of 1H-MRS. 결과:Proton MR spectra of chronic focal pancreatitis showed significantly diminished amount of lipids as compared with that of pancreatic cancer. The ratio of P(1.6-4.1ppm)/P(0.9-1.6ppm) in chronic focal pancreatitis was much higher than that of pancreatic cancer with a statistical significance (p<0.05) due to decreased peak area of lipids. Mean±standard deviation of P(1.6-4.1ppm)/P(0.9-1.6ppm) in chronic focal pancreatitis and pancreatic cance